SEC Comment Letter for MARRONE BIO INNOVATIONS INC (CIK 0001441693) — Feb 17, 2021
MARRONE BIO INNOVATIONS INC (CIK 0001441693)
Date: Feb. 17, 2021 · CIK: 0001441693 · Accession: 0000000000-21-001945
AI Filing Summary & Sentiment
File numbers found in text: 333-252823
Letter
United States securities and exchange commission logo February 17, 2021 Kevin Helash Chief Executive Officer Marrone Bio Innovations, Inc. 1540 Drew Avenue Davis, CA 95618 Re:Marrone Bio Innovations, Inc. Registration Statement on Form S-3 Filed February 8, 2021 File No. 333-252823 Dear Mr. Helash: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jordan Metoyer at 202-551-6001 or Ada D. Sarmento at 202-551- 3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Alfredo B.D. Silva, Esq.
Show Raw Text
United States securities and exchange commission logo
February 17, 2021
Kevin Helash
Chief Executive Officer
Marrone Bio Innovations, Inc.
1540 Drew Avenue
Davis, CA 95618
Re:Marrone Bio Innovations, Inc.
Registration Statement on Form S-3
Filed February 8, 2021
File No. 333-252823
Dear Mr. Helash:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jordan Metoyer at 202-551-6001 or Ada D. Sarmento at 202-551-
3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Alfredo B.D. Silva, Esq.